HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fiscal 2009 funded

This article was originally published in The Tan Sheet

Executive Summary

Congress passes and President Obama signs the Omnibus Appropriations Act of 2009 March 11 to fund the bulk of government agencies - including FDA - through the end of fiscal 2009. Under the $410 billion package, H.R. 1105, FDA is provided $2.6 billion for fiscal 2009 (1"The Tan Sheet" March 2, 2009, p. 9)

You may also be interested in...



Obama Budget Links Proposed User Fees To Improving Food Safety

The nearly $260 million increase President Obama requests for FDA's food safety operations includes $75 million in new user fees

Congress’ Omnibus Language Seeks FDA Progress Reports On Spending

Members of Congress want detailed quarterly updates from FDA on how the agency uses its 2009 appropriation, according to a joint explanatory statement accompanying the omnibus spending bill

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136378

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel